FR2650184A1 - Procede pour la preparation d'antigenes protecteurs de la coqueluche - Google Patents
Procede pour la preparation d'antigenes protecteurs de la coqueluche Download PDFInfo
- Publication number
- FR2650184A1 FR2650184A1 FR8910234A FR8910234A FR2650184A1 FR 2650184 A1 FR2650184 A1 FR 2650184A1 FR 8910234 A FR8910234 A FR 8910234A FR 8910234 A FR8910234 A FR 8910234A FR 2650184 A1 FR2650184 A1 FR 2650184A1
- Authority
- FR
- France
- Prior art keywords
- microbial
- preparation
- sodium chloride
- itaconic acid
- pertussis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000008569 process Effects 0.000 title claims abstract description 13
- 239000000427 antigen Substances 0.000 title claims description 26
- 102000036639 antigens Human genes 0.000 title claims description 26
- 108091007433 antigens Proteins 0.000 title claims description 26
- 238000002360 preparation method Methods 0.000 title claims description 20
- 230000001681 protective effect Effects 0.000 title claims description 15
- 230000000813 microbial effect Effects 0.000 claims abstract description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 26
- 239000000725 suspension Substances 0.000 claims abstract description 23
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims abstract description 16
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000002244 precipitate Substances 0.000 claims abstract description 11
- 239000011780 sodium chloride Substances 0.000 claims abstract description 11
- 239000000644 isotonic solution Substances 0.000 claims abstract description 9
- 201000005702 Pertussis Diseases 0.000 claims description 29
- 230000002779 inactivation Effects 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 5
- 229960005486 vaccine Drugs 0.000 abstract description 12
- 238000005119 centrifugation Methods 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 230000000415 inactivating effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010025280 Lymphocytosis Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 231100000563 toxic property Toxicity 0.000 description 2
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- -1 mercury ions Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8901975A NL8901975A (nl) | 1989-07-31 | 1989-07-31 | Werkwijze voor de bereiding van tegen kinkhoest-beschermende antigenen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2650184A1 true FR2650184A1 (fr) | 1991-02-01 |
Family
ID=19855129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8910234A Pending FR2650184A1 (fr) | 1989-07-31 | 1989-07-28 | Procede pour la preparation d'antigenes protecteurs de la coqueluche |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE3926206A1 (OSRAM) |
| FR (1) | FR2650184A1 (OSRAM) |
| HU (1) | HU53931A (OSRAM) |
| NL (1) | NL8901975A (OSRAM) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4429046A (en) * | 1982-07-26 | 1984-01-31 | American Cyanamid Company | Large scale cultivation of Bordetella pertussis cells for vaccine production |
-
1989
- 1989-07-28 FR FR8910234A patent/FR2650184A1/fr active Pending
- 1989-07-31 NL NL8901975A patent/NL8901975A/nl not_active Application Discontinuation
- 1989-08-02 HU HU393989A patent/HU53931A/hu unknown
- 1989-08-08 DE DE19893926206 patent/DE3926206A1/de not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4429046A (en) * | 1982-07-26 | 1984-01-31 | American Cyanamid Company | Large scale cultivation of Bordetella pertussis cells for vaccine production |
Also Published As
| Publication number | Publication date |
|---|---|
| HU53931A (OSRAM) | 1990-12-28 |
| DE3926206A1 (de) | 1991-02-14 |
| NL8901975A (nl) | 1991-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4687738A (en) | Method for the production of HA fraction containing protective antigens of Bordetella pertussis and pertussis vaccine | |
| DE69124235T2 (de) | Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins | |
| LU85197A1 (fr) | Procede de production de proteines correspondant a la toxine diphterique | |
| Katsuwon et al. | Catalase and superoxide dismutase of root-colonizing saprophytic fluorescent pseudomonads | |
| Hueppe | The principles of bacteriology | |
| Takahashi | A virus inactivator from yeast | |
| CN120866169A (zh) | 一株多粘类芽孢杆菌b01及其应用 | |
| Youmans et al. | The inactivation of isoniazid by filtrates and extracts of mycobacteria | |
| FR2650184A1 (fr) | Procede pour la preparation d'antigenes protecteurs de la coqueluche | |
| DE1941768C3 (de) | Verfahren zur Herstellung von Uricase | |
| CN110237251A (zh) | 一种复合特异性卵黄抗体口腔喷雾剂及其制备方法 | |
| US20030232422A1 (en) | Materials and methods for in vitro production of bacteria | |
| Ross | Photodynamic action of methylene blue on antipneumococcal serum | |
| US3208909A (en) | Anaerobic process for production of a gel-adsorbed anthrax immunizing antigen | |
| Kindler et al. | Production of toxin by resting cells of Cl. parabotulinum type A | |
| JPH0617291B2 (ja) | ナス科植物の土壌病害防除方法 | |
| EP0158285B1 (de) | Verfahren zur Gewinnung von Zellkulturen | |
| JPS6153033B2 (OSRAM) | ||
| JPS6339595A (ja) | アルカロイドの製造方法 | |
| KR20180121311A (ko) | 셀레늄 저항성 신규 미세조류 | |
| JPH0393729A (ja) | 百日咳保護抗原の製造方法 | |
| JP2021013313A (ja) | 新規微細藻類 | |
| McCarty et al. | Studies on the chemical nature of the substance inducing transformation of pneumococcal types | |
| RU2148412C1 (ru) | Способ получения протективного коклюшного антигена | |
| Twort et al. | An Investigagtion on Influenza |